Evidence map›Paper›PMID 40610573›Full record

ArticleScientific reports2025

Diagnostic whole exome sequencing in presumably autosomal recessive inherited retinal dystrophies in an Iranian population.

Pam A T Heutinck, Adriana I Iglesias, Dariush D Farhud, Marianne van Tienhoven, Atiyeh Khoshraftar, Marjan Zarif-Yeganeh, Sima Kheradmand Kia, Mohsen Ghanbari, Magda A Smoor, Caroline C W Klaver and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Pam A T HeutinckDepartment of Ophthalmology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Adriana I IglesiasDepartment of Clinical Genetics, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Dariush D FarhudSchool of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Marianne van TienhovenDepartment of Clinical Genetics, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Atiyeh KhoshraftarDoctor Farhud Genetics Clinic, Tehran, Iran.
Marjan Zarif-YeganehDoctor Farhud Genetics Clinic, Tehran, Iran.
Sima Kheradmand KiaLaboratory for Red Blood Cell Diagnostics, Sanquin, Amsterdam, The Netherlands.
Mohsen GhanbariDepartment of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Magda A SmoorDepartment of Ophthalmology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Caroline C W KlaverDepartment of Ophthalmology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Lies H HoefslootDepartment of Clinical Genetics, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Alberta A H J Thiadens *Department of Ophthalmology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Virginie J M Verhoeven *Department of Ophthalmology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. v.verhoeven@erasmusmc.nl.

Funding

Algemene Nederlandse Vereniging ter voorkoming van Blindheid Through Uitzicht 2019-18Erasmus MC fellowship to VJM Verhoeven Year 2021Landelijke Stichting voor Blinden en Slechtzienden Through Uitzicht 2019-18Stichting Steunfonds Uitzicht 2019-18
6 · The paper itself

Abstract

Advances in genetic testing have improved IRD diagnostics and counseling. To enhance these advances and contribute to an inclusive genetic landscape, this study examines genetic causes in 111 Iranian patients clinically diagnosed with non-syndromic IRD (48% males, > 90% born to consanguineous parents, median age at genetic examination of 37 years (interquartile range 30-42)). Patients were analyzed by ethnicity. Whole exome sequencing using a vision disorder gene panel, including copy number variations analysis, was performed at Erasmus MC. Variants were classified per American College of Medical Genetics and Genomics guidelines, with clinical significance assessed via public databases. Genetic causes were identified in 66 patients (59%) across 31 genes, including 14 novel variants. Five patients were diagnosed with syndromic IRD based on genetic findings. Homozygous variants, indicating autosomal recessive (AR) inheritance, were detected in 62 patients (94%). The most affected genes were CERKL (n = 8), EYS (n = 7), and RPE65 (n = 6), with CERKL most common in Turks (n = 6), RPE65 in Kurds (n = 4), and EYS in Fars (n = 3). Variants of uncertain significance were identified in 35 patients (32%). This study identified 14 novel variants and a high prevalence of AR inheritance, underscoring the necessity of tailored genetic counseling and the importance of incorporating diverse populations into genetic research.

Indexed as

Exome SequencingGenes, RecessiveRetinal DystrophiesAdultDNA Copy Number VariationsFemaleGenetic TestingHumansIranMale

Identifiers

PMID40610573
PMCPMC12229322

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.